Research on development of diagnostic tests for the novel coronavirus disease (COVID-19)

Key facts

Disease
COVID-19
Start & end year
2019
2019
Funder
Japan Agency for Medical Research and Development (AMED)
Principal Investigator
SUZUKI Tadaki
Research Location
Japan
Lead Research Institution
National Institute of Infectious Diseases, Japan
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

The research group will aim to develop the basic technology for use in rapid diagnostic test kits for SARS-CoV-2. The group will focus on molecular and antibody based diagnostic technologies such as RT-LAMP, SARS-CoV-2 antigen detection assay, and anti-viral antibody detection assay. The group will also conduct viral genome analysis using clinical samples to develop robust diagnostic tests for SARS-CoV-2